Answer
Headache and drowsiness (somnolence) are both common with Optivate, each affecting at least 1 in 100 but fewer than 1 in 10 patients.
Sources for this answer
- Optivate 100 IU/ml powder and solvent for solution for injectionBio Products Laboratory Limited · emc · SmPC §4.8 Undesirable effects · Version 3Document updated
Sources checked